1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Investigating the genetic architecture of dementia with Lewy bodies : a two-stage genome-wide association study
(
- Contribution to journal › Article
- 2017
-
Mark
Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
(
- Contribution to journal › Article
-
Mark
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
(
- Contribution to journal › Article
- 2016
-
Mark
Deletions at 22q11.2 in idiopathic Parkinson's disease : a combined analysis of genome-wide association data
(
- Contribution to journal › Article
-
Mark
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
(
- Contribution to journal › Article
-
Mark
A genome-wide association study in multiple system atrophy
(
- Contribution to journal › Article
- 2015
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of Dementia with Lewy Bodies.
(
- Contribution to journal › Article
- 2013
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
- 2011
-
Mark
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
(
- Contribution to journal › Article